With regards to the 4/15 deadline, these are the possibilities (you may add more as per your analysis):
1. Another 6 month extension. Reason: Things are probably taking longer than expected in clinical trials, making decisions difficult for Celgene.
2. A licensing deal is announced
3. Current agreement is terminated by one or both parties (I hope not)
So impact on the share price would be, for each of the 3 scenarios above (guesses of course!):
1. No impact. We trade at curent levels until the next price sensitive announcement (whatever that may be)
2. The share price shoots up
3. The share price takes a hit. (In this scenario, would Celgene dump their 15.3 million shares, even if it were for a loss or wait until break even in the future and then sell?)
I could not find what (if) terms they agreed to in case the agreement is terminated.
- Forums
- ASX - By Stock
- MSB
- Celgene Agreement
Celgene Agreement
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 75212 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 1.185 |
4 | 69624 | 1.180 |
3 | 122218 | 1.175 |
3 | 86297 | 1.170 |
2 | 52098 | 1.165 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 75212 | 5 |
1.195 | 71199 | 8 |
1.200 | 793756 | 45 |
1.205 | 83717 | 4 |
1.210 | 193114 | 8 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |